Legal provisions of COM(2017)742 - Amendment of Council Directive 92/66/EEC introducing Community measures for the control of Newcastle disease

Please note

This page contains a limited version of this dossier in the EU Monitor.

dossier COM(2017)742 - Amendment of Council Directive 92/66/EEC introducing Community measures for the control of Newcastle disease.
document COM(2017)742 EN
date April 18, 2018

Contents

Article 1 - Amendments to Directive 92/66/EEC

Directive 92/66/EEC is amended as follows:

(1)Article 15 is replaced by the following:

‘Article 15

1. The Commission shall, by means of implementing acts, designate a European Union reference laboratory for Newcastle disease. Those implementing acts shall be adopted in accordance with the examination procedure referred to in Article 25.

2. The functions and duties of the European Union reference laboratory for Newcastle disease shall be:

(a)to coordinate, in consultation with the Commission, the methods employed in the Member States for diagnosing Newcastle disease, specifically by:

(i)typing, storing and supplying strains of Newcastle disease virus for serological tests and the preparation of antisera;

(ii)supplying standard sera and other reference reagents to the national reference laboratories in order to standardise the tests and reagents used in the Member States;

(iii)building up and retaining a collection of Newcastle disease virus strains and isolates;

(iv)organising periodical comparative tests of diagnostic procedures at Union level;

(v)collecting and collating data and information on the methods of diagnosis used and the results of tests carried out in the Union;

(vi)characterising isolates of Newcastle disease viruses by the most up-to-date methods available to promote a greater understanding of the epidemiology of Newcastle disease;

(vii)keeping abreast of developments in Newcastle disease surveillance, epidemiology and prevention throughout the world;

(viii)retaining expertise on Newcastle disease virus and other pertinent viruses to enable a rapid differential diagnosis;

(ix)acquiring a thorough knowledge of the preparation and use of the products of veterinary immunology used to eradicate and control Newcastle disease;

(b)to actively assist in the diagnosis of outbreaks of Newcastle disease in Member States by receiving virus isolates for confirmatory diagnosis, characterisation and epidemiology studies;

(c)to facilitate the training or retraining of experts in laboratory diagnosis with a view to the harmonisation of techniques throughout the Union.’;

(2)Article 19 is amended as follows:

(a)paragraph 5 is replaced by the following:

‘5.   To the extent that it is required for the proper application of the measures laid down in this Article, the Member States shall submit to the Commission, within the framework of the Standing Committee on Plants, Animals, Food and Feed, information on the disease situation and the control measures applied.’;

(b)the following paragraph is added:

‘6.   The Commission may, by means of implementing acts, lay down rules regarding the information to be submitted by the Member States to the Commission as provided for in paragraph 5 of this Article. Those implementing acts shall be adopted in accordance with the examination procedure referred to in Article 25.’;

(3)Article 21 is replaced by the following:

‘Article 21

1. Each Member State shall draw up a contingency plan, specifying the national measures to be implemented in the event of an outbreak of Newcastle disease. The contingency plan shall be updated, as appropriate, to take account of developments in the situation.

The contingency plan shall allow access to facilities, equipment, personnel and all other appropriate materials necessary for the rapid and efficient eradication of the outbreak of Newcastle disease. It shall give a precise indication of the vaccine requirements which each Member State deems necessary for emergency vaccination.

2. The contingency plans and any updates thereto shall be submitted to the Commission.

3. The Commission shall examine the contingency plans and any updates thereto in order to determine whether they permit the desired objective to be attained and shall suggest to the Member State concerned any amendments required in particular to ensure that they are compatible with those of the other Member States.

The Commission shall approve the contingency plans and any updates thereto, if necessary amended, in accordance with the examination procedure referred to in Article 25.

4. The Commission may, by means of implementing acts, lay down criteria to be applied by Member States for drawing up the contingency plans. Those implementing acts shall be adopted in accordance with the examination procedure referred to in Article 25.’;

(4)Article 25 is replaced by the following:

‘Article 25

1. The Commission shall be assisted by the Standing Committee on Plants, Animals, Food and Feed established by Article 58(1) of Regulation (EC) No 178/2002 of the European Parliament and of the Council (*1). That committee shall be a committee within the meaning of Regulation (EU) No 182/2011 of the European Parliament and of the Council (*2).

2. Where reference is made to this Article, Article 5 of Regulation (EU) No 182/2011 shall apply.

(5)Annexes V, VI and VII are deleted.

Article 2 - Transposition

By 30 June 2018, Member States shall adopt and publish the measures necessary to comply with this Directive. They shall immediately inform the Commission thereof.

They shall apply those measures from 1 January 2019.

When Member States adopt those measures, they shall contain a reference to this Directive or shall be accompanied by such reference on the occasion of their official publication. The methods of making such reference shall be laid down by Member States.

Article 3 - Transitional provision

The designation of the European Union reference laboratory for Newcastle disease referred to in Annex V to Directive 92/66/EEC, before the amendments made by this Directive, shall remain effective until a European Union reference laboratory for Newcastle disease has been duly designated in accordance with Article 15 of Directive 92/66/EEC, as amended by this Directive.

Article 4 - Entry into force

This Directive shall enter into force on the day following that of its publication in the Official Journal of the European Union.

Article 5 - Addressees

This Directive is addressed to the Member States.